The story has been corrected to reflect the correct amount of Guardant Health's financing round in January 2016.

NEW YORK (GenomeWeb) – Guardant Health today announced it has raised $360 million to finance a new goal to sequence the tumor DNA of more than 1 million cancer patients within five years.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.